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Commun i c a t i o n
I N T RODUC T I ON
Voltage-gated potassium (Kv) channels play diverse roles 
including controlling the repolarization phase of action 
potentials in electrically excitable cells throughout the 
brain and body. In mammals, Kv channels arise from 
a family of 40 genes encoding pore-forming subunits 
(Gutman et al., 2005). This genetic diversity is greater 
than any other family of ion channels, and individual 
cells express an array of different Kv types. Each chan-
nel type has a distinct subcellular distribution and func-
tional properties to make a unique contribution to 
electrical signaling (Vacher et al., 2008). Selectively in-
hibiting Kv subtypes is a promising method of tuning 
electrical excitability for research and clinical purposes, 
yet has been difficult in practice.
The diversity of Kv channels poses a challenge to 
biomedical science. The contribution to electrical sig-
naling of any individual channel type is difficult to con-
clusively demonstrate. Hence, the precise physiological 
function of most Kv subunits remains unknown. For 
most Kv subunits, drugs of great selectivity have not yet 
been discovered. In the rare cases where selective Kv 
inhibitors have been found, they have proven indis-
pensable in identifying channel functions. For example, 
extensive efforts to develop pharmacology selective for 
Kv channels in human T lymphocytes (DeCoursey et al., 
1984; Grissmer et al., 1990; Lin et al., 1993) led to the 
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identification of the pivotal role of Kv1.3 in immune ac-
tivation, and the channel is now the target of several 
drugs in clinical trials (Beeton et al., 2006; Tarcha et al., 
2012). For most Kv channels, researchers rely on a patch-
work pharmacology insufficient to conclusively identify 
the function of specific channel types. Because of the 
inadequacy of subtype-selective Kv drugs, the limiting 
step in developing Kv therapies remains the process of 
identifying a specific channel type as a target for drug 
development, or “target validation” (Kaczorowski et al., 
2008; Rhodes and Trimmer, 2008). Ideally, to identify 
the physiological roles of Kv channels, a selective drug 
would be available for every Kv type.
Selective antibodies have been developed against 
most Kv subunits (Vacher et al., 2008). However, gen-
eration of antibodies that inhibit ionic current has 
proven difficult. There are several publications describ-
ing inhibitory antibodies that target Kv subunits (Zhou 
et al., 1998; Murakoshi and Trimmer, 1999; Jiang et al., 
2003; Xu et al., 2006; Gómez-Varela et al., 2007; Yang 
et al., 2012), but none of these antibodies has yet emerged 
with the qualities required for widespread use (Dallas 
et al., 2010). What would be most useful to researchers 
are mAbs against extracellular epitopes that robustly 
modulate function of mammalian Kv channels.
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A family of 40 mammalian voltage-gated potassium (Kv) channels control membrane excitability in electrically 
excitable cells. The contribution of individual Kv channel types to electrophysiological signaling has been difficult 
to assign, as few selective inhibitors exist for individual Kv subunits. Guided by the exquisite selectivity of immune 
system interactions, we find potential for antibody conjugates as selective Kv inhibitors. Here, functionally benign 
anti-Kv channel monoclonal antibodies (mAbs) were chemically modified to facilitate photoablation of K currents. 
Antibodies were conjugated to porphyrin compounds that upon photostimulation inflict localized oxidative dam-
age. Anti-Kv4.2 mAb–porphyrin conjugates facilitated photoablation of Kv4.2 currents. The degree of K current 
ablation was dependent on photon dose and conjugate concentration. Kv channel photoablation was selective for 
Kv4.2 over Kv4.3 or Kv2.1, yielding specificity not present in existing neurotoxins or other Kv channel inhibitors. 
We conclude that antibody–porphyrin conjugates are capable of selective photoablation of Kv currents. These 
findings demonstrate that subtype-specific mAbs that in themselves do not modulate ion channel function are 
capable of delivering functional payloads to specific ion channel targets.
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and there are reports of mAbs targeting porphyrins to 
cancer cells (Alonso et al., 2010; Palumbo et al., 2011). 
Here, we target porphyrin photosensitizers with sub-
type-specific mAbs. We find that currents from Kv chan-
nels can be selectively ablated by photostimulation of 
antibody-conjugated porphyrins.
MAT E R I A L S  AND  M E THOD S
Antibody validation
To target photoinhibitors to Kv channels, an extensively vali-
dated, subtype-selective anti-Kv mAb was chosen. The IgG1 clone 
K57/1 (Shibata et al., 2003) was found to be selective for mam-
malian Kv4.2 channels (Rhodes et al., 2004; Menegola and Trimmer, 
2006), has been used for studies by multiple research groups 
(Burkhalter et al., 2006; Gardoni et al., 2007; Kim et al., 2007; 
Amarillo et al., 2008; Hammond et al., 2008), and is publicly avail-
able from the UC Davis/National Institutes of Health NeuroMab 
facility. The K57/1 mAb was generated against a synthetic peptide, 
“Kv4.2e,” that mimicked amino acids of the external loop between 
the S1 and S2 segment of the human Kv4.2 subunit (Fig. 1 A). 
The S1–S2 linker is the longest and most variable external region 
of Kv proteins and, as such, is an attractive target for generating 
subtype-specific externally acting antibodies. The Kv4.2e se-
quence is identical in human, rat, mouse, and other mammalian 
Kv4.2 orthologues. The K57/1 antibody is highly specific for 
Kv4.2 over its closely related family members Kv4.1 and Kv4.3 
(Rhodes et al., 2004). K57/1 exhibits robust binding in immuno-
histochemical staining of the intact brains and in immunoblot 
analyses of denatured protein samples prepared from wild-type 
mice did not exhibit detectable signals in Kv4.2 knockout mice 
(Fig. 2, B and C) (Menegola and Trimmer, 2006). To date, all 
anti-Kv channel S1–S2 linker antibodies we have tested, including 
the K57/1 mAb, have proven ineffectual as inhibitors of their tar-
geted Kv channels (Fig. 1 D).
Immunoblots
All animals were cared for and euthanized in accordance with 
institutional animal use protocols. Rat and mouse brain mem-
branes were prepared as described previously (Shi et al., 1994). 
Mouse brain membranes were prepared from brains of Kv4.2 
knockout mice (Guo et al., 2005) and wild-type littermates. In 
brief, brains from adult rats and mice were homogenized in 5 mM 
sodium phosphate buffer (PB), pH 7.4, containing 320 mM sucrose 
and 100 mM NaF. The homogenate was centrifuged at 800 g for 
10 min to remove nuclei and unbroken tissues, and then centri-
fuged at 100,000 g to prepare a membrane fraction. Membranes 
were diluted with the sample buffer for SDS-PAGE. Molecular 
weight standards were Amersham Rainbow Markers (RPN800). 
Proteins were separated by SDS-PAGE on 7.5% gels, transferred 
to nitrocellulose membranes, and immunoblotted with anti-Kv4.2 
K57/1 or anti-Kv2.1 K89/41 (Antonucci et al., 2001) mouse mAb 
tissue culture supernatants at 1:2. The blots were incubated with 
horseradish peroxidase–conjugated secondary antibodies (MP 
Biomedicals), followed by enhanced chemiluminescence reagent 
(PerkinElmer). Immunoreactive bands were visualized by expos-
ing the blot to x-ray film.
Immunofluorescence staining of brain sections
Mice were deeply anesthetized with sodium pentobarbital (60 mg/kg, 
intraperitoneally) and perfused through the ascending aorta with 
20 ml of 0.9% saline, followed by 80 ml of fixative containing 
4% formaldehyde, prepared from freshly depolymerized parafor-
maldehyde, in 0.1 M PB. The brains were removed, cryoprotected 
We have generated several mAbs that bind epitopes 
on the external face of Kv channels. These exhibit clear 
specificity for Kv subtypes, including Kv1.1 (Tiffany et al., 
2000), Kv2.1 (Lim et al., 2000), and Kv4.2 (Shibata et al., 
2003). None of these mAbs has been found to inhibit 
currents. Our objective is to harness the exquisite selectiv-
ity of these mAbs to selectively modulate Kv function. By 
attaching inhibitory moieties to subtype-selective mAbs, 
we aim to find a solution to the problematic scarcity of 
selective Kv inhibitors that can be applied to all subtypes.
In this communication, we report a means of imbu-
ing benign anti-Kv mAbs with inhibitory potency. Our 
strategy for targeted inhibition of Kv channels was to 
label antibodies with chromophores that induce oxida-
tive damage to the target protein upon photostimula-
tion. Such strategies have proven useful to permanently 
inhibit proteins (Beck et al., 2002; Lee et al., 2008). Re-
lated strategies involving genetically targeted photosensi-
tizers have also proven to be a viable means of inhibiting 
membrane proteins including ion channels and aqua-
porins (Tour et al., 2003; Baumgart et al., 2012). In all 
of these strategies, photostimulation of certain chromo-
phores leads to the local generation of reactive oxygen 
species. The lifetime of the reactive species determines 
its diffusional distance and hence a radius of localized 
oxidative damage. One extensively used species is sin-
glet oxygen, which has an 40-Å half-maximal radius of 
oxidative damage (Beck et al., 2002; Vegh et al., 2011). 
Oxidative damage mediated by singlet oxygen has 
proven capable of ablating the function of a wide range 
of protein targets but also results in varying degrees of 
collateral damage to other cell components (Guo et al., 
2006). As the use of efficient reactive oxygen–generat-
ing species may help minimize unintended damage, we 
sought to find chromophores with optimal properties. 
In this work, we test the capacity of porphyrin conjugates 
to mediate photoablation of ionic currents. Porphyrins 
are among the most efficient photo-induced generators 
of singlet oxygen known. For example, 5,10,15,20-tetrakis 
(1-methylpyridinium-4-yl)porphine, which is closely re-
lated to the photosensitizer, 1, used here (Fig. 2 A), has 
a singlet oxygen quantum yield in water of 0.74 (Verlhac 
et al., 1984). This is far higher than the quantum yield 
of 0.03–0.06 reported for fluorescein (Wilkinson et al., 
1993), which is classically used for targeted photoabla-
tion of protein function (Redmond and Gamlin, 1999; 
Smith et al., 2011). Additionally, as with most porphy-
rins, our photosensitizer, 1, has a greater maximal ex-
tinction coefficient, 425 nm = 220,000 M1 cm1 (Tomé 
et al., 2004), than fluorescein, 490 nm = 76,900 M1 cm1 
(Sjoback et al., 1998). Because of their efficient photo-
stimulated generation of reactive oxygen, porphyrins 
are used clinically in photodynamic therapy for cancer 
treatment (Bonnett, 1995; Agostinis et al., 2011). We 
have previously used virus capsids loaded with porphy-
rins to target cancer cells (Stephanopoulos et al., 2010), 
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secondary antibodies conjugated to Alexa Fluors (Life Technolo-
gies). Sections were then washed again for 5 min each in vehicle, 
0.1 M PB, and 0.05 M PB, and mounted on gelatin-coated slides, 
dried, and coverslipped using mounting medium (ProLong Gold; 
Life Technologies).
Fluorescence images were taken using the same exposure time 
for each set of samples to directly compare the signal intensity. 
Images were acquired with a charge-coupled device camera installed 
on an Axiovert 200-M microscope with a 20×, 0.8 numerical aper-
ture lens, and an ApoTome coupled to Axiovision software (Carl 
Zeiss). Images were exported from Axiovision as TIFF or JPEG 
files and imported into Photoshop (Adobe).
Porphyrin synthesis and antibody conjugation
To imbue antibodies with photoinhibitory functionality, water-
soluble porphyrin compounds were synthesized and functional-
ized for conjugation to proteins. The porphyrin ring is aromatic 
and hydrophobic, with sparing water solubility. The porphyrins 
used in this work were chemically altered to increase their hydro-
philicity by appending charged moieties to three of the four aryl 
groups projecting from the porphyrin ring. Positive charges were 
introduced by using methylated pyridine derivatives, and negative 
charges were introduced by attaching sulfonate groups to the aryl 
rings (Fig. 2 A). The fourth aryl group projecting from the por-
phyrin core was engineered for linkage to antibodies. Porphyrins 
were synthesized for three conjugation strategies: porphyrin 1 for 
N-hydroxysuccinimide–mediated addition to mAb primary amine 
groups (e.g., lysines); porphyrin 2 for isothiocyanate-mediated 
addition to primary amine groups; and porphyrin 3 for the conju-
gation of aminooxy groups to aldehydes/ketones introduced into 
the antibody amino termini using a pyridoxal-6-phosphate–medi-
ated transamination reaction (Gilmore et al., 2006; Scheck and 
Francis, 2007). Water-soluble porphyrins were reacted with K57/1 
antibody (Fig. 2 B), and these antibody–porphyrin conjugates 
tested for photoinhibitory activity against Kv channels.
Cationic porphyrin-NHS ester 1 (Fig. 2 A) was prepared accord-
ing to a published procedure (Tomé et al., 2004). The final prod-
uct was stored at 20°C as a 10-mM solution in DMSO. Anti-Kv4.2 
antibody porphyrin 1 conjugate (Kv4.2•1) was prepared as fol-
lows: anti-Kv4.2 mAb K57/1 (Shibata et al., 2003) was initially pu-
rified from ascites fluid, as described previously (Trimmer et al., 
1985). The antibody was further purified by elution from protein 
G sepharose (GE Healthcare), with 0.5 M acetic acid, neutraliza-
tion with 0.6 volumes of 1 M sodium phosphate, pH 8.0, concen-
tration in a centrifugal filter unit (30 K Amicon-4; EMD Millipore), 
and dialysis against 100 mM sodium phosphate, pH 8. In an opaque 
black polypropylene tube, with precautions taken to minimize 
light exposure, purified mAb (7 µM) was mixed with 16 equiva-
lents of cationic porphyrin-NHS in DMSO, for 10% final DMSO 
concentration. The reaction vessel was purged with argon, and 
the reaction allowed to proceed for 3 h at 4°C, before termination 
by application to a desalting resin (Zeba; Thermo Fisher Scien-
tific) preequilibrated with 150 mM NaCl and 10 mM PB, pH 7.3. 
The degree of antibody modification was approximately two por-
phyrins per antibody molecule, as determined from absorbance 
readings (Fig. 2 C) on wavelength-scanning spectrophotometer 
(Cary 50 Scan; Varian) using extinction coefficients (M1 cm1) 
porphyrin 1, 280 nm = 10,000 and 425 nm = 220,000, and IgG, 280 nm = 
210,000. This mAb–porphyrin conjugate, Kv4.2•1, was protected 
from light and stored with 1% BSA (03117332001; Roche) and 
10 mM sodium azide at 4°C until use.
Anionic porphyrin isothiocyanate 2 (Fig. 2 A) was synthesized 
from 5-(4-aminophenyl)-10,15,20-tris(4-sulfonatophenyl)porphy-
rin, tris(n-tetrabutylamminonium) salt, according to published 
procedures (Endo et al., 2007; Stephanopoulos et al., 2009) as 
follows: the starting porphyrin (16 mg, 0.01 mmol) was dissolved 
in 4 ml anhydrous dichloromethane (DCM). To this solution was 
for 18–48 h in 20% sucrose, frozen in a bed of pulverized dry ice, 
and then cut into 40-µm sagittal sections on a sliding microtome 
(Michrom HM 450; Richard-Allan Scientific) equipped with a 
freezing stage (BFS-30TC and PTU-3; Physitemp). Sections were 
collected in 0.1 M PB and processed immediately for immuno-
histochemistry as described below.
For immunohistochemistry, sections were washed four times 
for 5 min each in ice cold 0.1 M PB and blocked for 1 h at 4°C 
in vehicle (10% goat serum, 0.1 M PB, and 0.3% Triton X-100). 
Sections were incubated overnight at 4°C in vehicle containing 
anti-Kv4.2 mouse mAb K57/1 and anti-Kv2.1 affinity-purified 
rabbit polyclonal antibody KC (Trimmer, 1991). Sections were 
washed four times for 5 min each in vehicle and incubated for 
1 h in vehicle containing affinity-purified, species-specific goat 
Figure 1. Validation of anti-Kv4.2 mAb. (A) Sequence alignment 
of relevant K channels indicating residues included in Kv4.2 
immunogenic peptide. (B) Immunohistochemical analysis of anti-
body specificity in brain. Double-label immunofluorescence stain-
ing for anti-Kv4.2 mAb (red) and anti-Kv2.1 polyclonal antibody 
(green) in sections prepared from the brains of wild-type (top row) 
and Kv4.2 knockout (bottom row) mice. (C) Immunoblot analysis 
of antibody specificity in brain. Immunoblot of adult rat brain 
membranes (RBM), adult mouse brain membranes from Kv4.2 
knockout (MBM-Kv4.2-KO), and wild-type (MBM-WT) mice probed 
with anti-Kv4.2 or anti-Kv2.1 mAbs as noted. Numbers to the left 
denote mobility of prestained molecular weight standards in kilo-
daltons. (D) Whole cell Kv4.2 current from a 0-mV pulse before 
and 8 min after the application of 1 µM anti-Kv4.2 mAb K57/1 to 
a HEK cell. P/5 subtraction was used to isolate K currents.
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ELISAs
The anti-Kv4.2 mAb K57/1 was generated against a synthetic pep-
tide, Kv4.2e, CGSSPGHIKELPSGERY, in which the second cysteine 
from the corresponding Kv4.2 sequence (Fig. 1 A) was changed 
to serine for chemistry considerations (Shibata et al., 2003). The 
Kv4.2e peptide was conjugated to BSA by its amino-terminal cyste-
ine and prepared as follows: a 0.5-ml aliquot of 10 mg/ml BSA 
dialyzed against 50 mM sodium phosphate, pH 6.0, was incubated 
with 800 µg sulfo-MBS (Thermo Fisher Scientific) on a tube rota-
tor at room temp for 30 min. The product was passed through a 
G-50 column (Sephadex) equilibrated in 50 mM sodium phos-
phate, pH 6.0, to remove unconjugated sulfo-MBS. The peak 1-ml 
BSA fraction was added to 5 mg synthetic peptide dissolved in 
0.5 ml of 1 mM EDTA and 20 mM sodium phosphate, pH 7.2, and 
rotated overnight at room temperature; aliquots were stored at 
20°C until use.
96-well microtiter plates (655081; Greiner) were coated with 
50 µl of 50 µg/ml Kv4.2e-BSA conjugate or a BSA control in 10 mM 
sodium azide overnight at 4°C. After a 45-min block with blotto 
(20 mM Tris HCl, pH 8, 150 mM NaCl, 4% nonfat dry milk, and 
0.1% Tween 20) at room temperature, 50-µl primary antibody 
dilutions in blotto ± blocking peptide were added to wells and 
rocked gently for 45 min at room temperature. The 1° antibody 
solution was removed, and wells were washed with blotto three 
times at 5-min intervals, followed by a 45-min incubation with 
goat anti–mouse heavy and light chain–specific 2° antibody–
horseradish peroxidase conjugate (KPL 474–1806) diluted at 
1:5,000 in blotto. Wells were then washed three times at 5-min 
intervals with PBS (150 mM NaCl and 10 mM sodium phos-
phate, pH 7) and developed in 50 µl 3,3,5,5-tetramethylben-
zidine solution (34028; Thermo Fisher Scientific) for 5 min 
before stop with 50 µl of 2 M sulfuric acid. Absorbance at 450 nm 
was quantified.
added 1,1-thiocarbonyldi-2(1H)-pyridone (5 mg, 0.02 mmol) in 
1 ml DCM. The reaction was stirred at room temperature and 
reacted to completion in 2 h, as monitored by matrix-assisted 
laser desorption/ionization–time of flight (MALDI-TOF) mass 
spectroscopy. The solvent was removed under reduced pressure. 
The crude mixture was dissolved in DCM and product purified by 
silica gel chromatography, first using 10% methanol in DCM to 
elute unreacted pyridone, and then 50% methanol in DCM to 
elute the porphyrin. Product purity was verified by MALDI-TOF 
mass spectrometry. Solvent was removed under reduced pressure, 
and the porphyrin was stored at 20°C as a 20-mM solution in 
DMSO. To the purified K57/1 antibody (7 µM) in 0.5 M sodium 
bicarbonate, pH 9.2, 16 equivalents of anionic porphyrin 2 in 
DMSO were added, for a 10% final concentration of DMSO. The 
reaction vessel was purged with argon, and reaction was allowed 
to proceed for 1 h on ice. This conjugate, Kv4.2•2, was prepared 
as described above for Kv4.2•1.
Anionic porphyrin alkoxyamine 3 (Fig. 2 A) was prepared as 
described previously (Stephanopoulos et al., 2009) and was stored 
in DMSO until use. For conjugation to the antibody, it was first 
necessary to generate a ketone at the amino terminus of the anti-
body using a pyridoxal 5-phosphate–based transamination reac-
tion, as described previously (Gilmore et al., 2006). In brief, the 
K57/1 antibody (7 µM) in 50 mM phosphate buffer, pH 6.5, was 
exposed to 10 mM pyridoxal 5-phosphate and allowed to react 
overnight at room temperature. The reaction was terminated by 
application to a desalting resin (Zeba; Thermo Fisher Scientific) 
prequilibrated with 150 mM NaCl and 10 mM PB, pH 7.3. To this 
transaminated antibody, 10 equivalents of anionic porphyrin 3 in 
DMSO were added, for a 10% final concentration of DMSO. The 
reaction vessel was purged with argon, and reaction was allowed 
to proceed overnight at room temperature. This conjugate, 
Kv4.2•3, was prepared as described above for Kv4.2•1.
Figure 2. Porphyrin conjugation to mAbs. (A) Struc-
tures of porphyrins synthesized. (B) Schematic of por-
phyrin conjugation to a mAb. (C) Ultraviolet-visible 
absorption demonstrates that 420-nm absorbance is 
retained in conjugates. Spectrum of 1 (dashed line), 
scaled to match peak of Kv4.2•1 (solid line). Purple 
bar represents band-pass of illumination filter used in 
electrophysiology experiments. (D) Schematic of mAb-
mediated photoablation.
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(pipette) solution contained (mM): 50 KF, 70 KCl, 35 KOH, 5 
EGTA, and 50 HEPES, adjusted to pH 7.3 with HCl. A calculated 
liquid junction potential of 9.6 mV was corrected. Pipette tip resis-
tances with these solutions were <3 MΩ. Recordings were done at 
room temperature (22–24°C). Voltage clamp was achieved with 
an amplifier run by Patchmaster software (EPC-10; HEKA). The 
holding potential was 100 mV. Series resistance compensation 
was used when needed to constrain voltage error to <10 mV. When 
indicated, capacitance and ohmic leak were subtracted using a 
P/5 protocol. Recordings were low-pass filtered at 5 kHz and digi-
tized at 100 kHz. All recordings were made after the addition of 
0.1% BSA. Antibody–porphyrin conjugates were applied in external 
solution with 0.1% BSA at least 100 s before illumination, with light 
exposure kept to a minimum until illumination start. Antibodies 
were added by pipetting 100 µl of a 2× concentration into a record-
ing chamber (R-24N; Warner) containing 100 µl of solution.
Illumination for photoablation was administered by manually 
shuttering the epifluorescence input into a microscope (Axiovert 
100; Carl Zeiss). Light source was a 100-W mercury arc lamp fil-
tered by a 395–440-nm excitation filter (Zeiss filter set at 05). Unless 
noted otherwise, a 10× objective (1020–863; Carl Zeiss) was used 
for illumination. The total illumination output of the objective 
was 8–12 mW, as measured by a photodiode (S130VC; Thorlabs) 
calibrated at 425 nm. lllumination was adjusted by eye to be homo-
geneous across the field of view, with the patch-clamped cell cen-
tered in the field of view and plane of focus on the greatest diameter 
of the cell membrane.
Data analysis
Analysis and graphing were performed with IgorPro software 
(WaveMetrics), which performs nonlinear least-squares fits using 
a Levenberg–Marquardt algorithm. K current photoablation was 
fit with an exponential decay function:
 = + i ,rate timecurrent base Ae −   (1)
where time is the time elapsed since onset of illumination, rate is 
the photoablation rate, A is amplitude, and base is current remain-
ing at time = . The figure legends report rate ± SD and f ± SD, 
where f is the fraction of current ablated when current = base. 
When rate was so slow as to be poorly constrained (<0.01 s1), base 
was constrained to 0. This constraint did not alter the significance 
of any statistical comparisons. Significance was determined by 
rank using the nonparametric Mann–Whitney U test. Asterisks 
indicate P < 0.05. In the figures, electrophysiological current traces 
were digitally smoothed with a 2-kHz Gaussian filter. Error bars 
indicate mean ± SEM.
R E S U L T S
Antibody–porphyrin conjugates facilitate targeted  
K current photoablation
Antibody–porphyrin conjugates were added to the ex-
ternal solution of patch-clamped cells heterologously 
expressing Kv channels. After a brief incubation period 
to allow antibodies to bind channel targets, photostimu-
lation of the highest extinction coefficient absorption 
(Soret) band of the anti-Kv4.2 mAb–porphyrin 1 conju-
gate, Kv4.2•1 (Fig. 2 C), resulted in progressive inhibi-
tion of Kv4.2 current with photon dose (Fig. 3, A and B).
 This irreversible photoablation is consistent with oxida-
tive damage to channels from diffusible reactive oxygen 
species generated by photostimulated porphyrin, such 
Cell culture
CHO-K1 cells were maintained in Ham’s F12 media (Gibco) con-
taining 10% FBS (Hyclone) at 37°C in a 5% CO2 atmosphere. A 
stable Kv4.2 CHO-K1 cell line was generated with Kv4.2N2-31 
(Shibata et al., 2003) subcloned into a tetracycline-inducible 
expression system (TREx CHO; Life Technologies). 2 d after trans-
fection (Nucleofector; Lonza), 10 µg/ml blasticidin and 250 µg/ml 
zeocin were added to culture media. To induce channel expres-
sion for electrophysiological recording, 1 µg/ml tetracycline was 
added to the maintenance media for 10–20 h to induce a desir-
able amount of channel expression. The Kv2.1 TREx CHO cell line 
(Trapani and Korn, 2003) was cultured similarly and required 
1 µg/ml tetracycline for 1–2 h for channel expression. Kv4.3/
RGB4 (Rhodes et al., 2004) was transfected similarly with an EGFP/
pMax vector (Lonza), and currents were recorded 40–70 h after 
transfection. Kv4.2 HEK cells expressed a Kv4.2-GFP construct 
(Shibata et al., 2003), stably transfected into HEK293 cells, and were 
maintained in DMEM media containing 10% FBS and 500 µg/ml 
G418 (Life Technologies). For electrical recording, cells were 
harvested by scraping in a PBS with 1 mM EDTA (Versene; Life 
Technologies), pelleted at 1,000 g for 2 min, resuspended in CHO-
SFMII media (Life Technologies) supplemented with 25 mM 
HEPES, pH 7.3, and rolled in a polypropylene tube at room tem-
perature until use.
Electrophysiology
Whole cell voltage-clamp recordings were used to measure cur-
rents from Kv channels. Aliquots of cell suspension were added to 
a recording chamber and rinsed with external solution 5 or more 
minutes before recording. The external (bath) solution con-
tained (mM): 20 HEPES, 10 KOH, 117 NaCl, 2 CaCl2, 2 MgCl2, 
and 0.1 MgEDTA, adjusted to pH 7.3 with HCl. The internal 
Figure 3. Anti-Kv4.2 mAb–porphyrin conjugate facilitates pho-
toablation of K currents. (A) Kv4.2 currents during photoablation 
with 10 nM Kv4.2•1. Stimulatory pulses to 0 mV, with illumina-
tion beginning after time = 0. Data from CHO cell. (B) Circles, 
peak currents from cell in A. Purple bar indicates period of illumi-
nation. Line is fit of Eq. 1; rate = 0.053 ± 0.001 s1 and f = 0.953 ± 
0.004. (C) Peak Kv4.2 currents from cell similar to that in B, 
except conjugate was removed from bath solution for 2 min before 
illumination. Line is fit of Eq. 1; rate = 0.035 ± 0.003 s1 and f = 
0.82 ± 0.02.
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channel. Under more intense illumination, high photon 
doses yielded nonselective photoablation against all chan-
nels tested (Fig. 5). This suggests that the ability of the 
K57/1 antibody to recognize its epitope is compromised 
by attachment of the anionic conjugates. It is not clear why 
the anionic conjugates were not targeted as effectively as 
their cationic counterpart, Kv4.2•1. The weaker, nonse-
lective effects of Kv4.2• and Kv4.2•3, together with the 
off-target effects of Kv4.2•1 on Kv2.1 and Kv4.3, demon-
strate that a mechanism beyond antibody–epitope bind-
ing can also lead to photoablation. Yet, with this technique, 
nonselective side effects were dwarfed by selective anti-
body-guided photoablation of Kv currents.
To further test the mechanism of Kv subtype target-
ing, we probed the selectivity of mAb conjugates with a 
blocking peptide. Preincubation with soluble Kv4.2e 
peptide prevented binding of 5 nM anti-Kv4.2 mAb to 
its epitope, with an IC50 of 7 nM (Fig. 6, A and B). When 
mAb conjugates were preblocked with saturating con-
centrations of this soluble epitope, photoablation by 
the cationic porphyrin–antibody conjugate was reduced 
(Fig. 6 C). The Kv4.2•1 photoablation of Kv4.2 cur-
rents was not completely blocked by the antigenic pep-
tide, with the residual photoablation refractory to 
increased concentrations of peptide blocker. The block 
of photoablation by peptide is consistent with our other 
findings, where a degree of off-target effects accompany 
antibody-guided photoablation.
Targeted photoablation reduces K current magnitude 
without altering gating
The details of mAb-guided photoablation were investi-
gated to better understand how K current elimination 
as singlet oxygen, as schematized (Fig. 2 D). Photo-
ablation was also apparent after washout of mAb conju-
gate (Fig. 3 C), consistent with the conjugate channel 
complex having a slow dissociation rate from the tar-
geted channels.
The Kv4.2•1 porphyrin–mAb conjugates allowed selec-
tive photoablation of the targeted Kv channels. There was 
little photoablation of Kv4.3 or Kv2.1 in response to pho-
ton doses that eliminated Kv4.2 currents, suggesting that 
antibody targeting could direct the photoablation effect 
(Fig. 4). The effect of increasing photon dose was quanti-
fied as a photoablation rate, corresponding to the inverse 
time constant of current loss under our illumination con-
ditions (Fig. 4 E). With prolonged illumination, current 
was gradually lost from the off-target Kv2.1 and Kv4.3 
channels. This side effect indicated that although the anti-
Kv antibody could direct photoablation to channels of 
interest, collateral damage also occurred. Alternate por-
phyrin chemistries were not as successful at enabling tar-
geted photoablation. The mAb–porphyrin conjugates 
of the two anionic porphyrins synthesized (2 and 3) did 
not selectively ablate currents from the targeted Kv4.2 
Figure 4. Anti-Kv4.2 porphyrin conjugates selectively pho-
toinhibit Kv4.2. Photoablation of currents from Kv channels 
incubated with 10 nM Kv4.2•1. Data are from 0-mV pulses to 
patch-clamped whole CHO cells expressing the indicated chan-
nel. P/n leak subtraction was used to isolate K currents. (A) Lim-
ited inhibition of Kv4.3 currents. Black trace, before illumination; 
purple, after 10-s illumination; gray, after 100-s illumination. 
(B) Limited inhibition of Kv2.1 currents. Black trace, before illumi-
nation; purple, after 10-s illumination; gray, after 100-s illumina-
tion. (C) Circles, peak Kv4.3 currents. Purple bar indicates period 
of illumination. Line is fit of Eq. 1, with f = 1 and rate = 0.0045 ± 
0.002 s1. (D) Circles, peak Kv2.1 currents; rate = 0.00108 ± 
0.00004 s1. (E) Summary data of Kv subtype versus photoin-
hibitory rates derived from exponential fitting. Circles, individual 
cells. Kv4.2, n = 6; Kv4.3, n = 3; Kv2.1, n = 3.
Figure 5. Anionic porphyrin conjugates do not facilitate selec-
tive photoablation. Data points are relative peak currents during 
0-mV pulses to patch-clamped whole cells. Photon flux per unit 
area is approximately four times greater than in all other figures 
because of the 20× objective used. (A) Antibody–porphyrin 2 con-
jugate (20 nM) produced only nonselective photoablation of Kv 
currents. Black circles, Kv4.2 from HEK cells; rate = 0.012 ± 0.001 s1 
and f = 0.62 ± 0.04; gray circles, Kv2.1 from CHO cells; rate = 
0.014 ± 0.004 s1 and f = 0.48 ± 0.07. (B) Antibody–porphyrin 
3 conjugate (20 nM) produced only nonselective photoablation 
of Kv currents. Black circles, Kv4.2; rate = 0.016 ± 0.001 s1 and 
f = 0.75 ± 0.02; gray circles, Kv2.1; rate = 0.023 ± 0.004 s1 and f = 
0.49 ± 0.03.
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elicited before illumination, as were decaying tail currents 
from deactivation at negative voltages (Fig. 8 A), and 
inactivation (Fig. 3 A). The normal behavior of current 
remaining after photoablation contrasts with the progres-
sive alteration of the channel gating machinery, as is seen 
with cyclic nucleotide–gated channels (Middendorf and 
Aldrich, 2000; Middendorf et al., 2000). The extent of 
Kv photoablation could be halted at a given level by the 
termination of illumination (Fig. 8 B), indicating that 
the physical processes leading to irreversible current 
loss are rapid events, rather than the triggering of a slow 
decay process.
Photoablation inflicts collateral damage
The technique of porphyrin-mediated photoinhibition 
presents some technical difficulties that can complicate 
its application in the laboratory. Among these limita-
tions are an endogenous photosensitivity of Kv channel 
currents and leak currents in cell membranes that are 
sometimes induced by photostimulation of porphyrin–
mAb conjugates.
Limited Kv current photoablation was sometimes 
observed in the absence of porphyrins. Although pho-
tosensitivity of channels to the 420-nm illumination was 
usually not apparent without porphyrins added (Fig. 7 A), 
in certain cells there was a notable response to illumina-
tion, a particularly striking example of which is shown in 
Fig. 8 C. Although the endogenous photosensitivity com-
plicates interpretation, it never approached the rate of 
photoablation observed with antibody–porphyrin conju-
gates (Fig. 7 B). It is not clear what endogenous chro-
mophore may be mediating the response to illumination. 
occurs. The degree of photoablation was found to be 
dependent on the concentration of K57/1 antibody–
porphyrin conjugate applied. Increased concentration 
resulted in photoablation of a greater fraction of K cur-
rent (Fig. 7 A). During photostimulation, the rate of Kv4.2 
current decay did not reveal a consistent difference be-
tween the conjugate concentrations tested (Fig. 7 B). 
The dynamics of remaining current elicited from cells 
after partial photoablation was similar to control. The sig-
moid activation kinetics of Kv4.2 were similar to currents 
Figure 7. Dose dependence of photoablation. (A) Dose response 
of Kv4.2•1-mediated photoablation. Circles, relative peak cur-
rents from Kv4.2 CHO cells during 0-mV pulses with the indicated 
concentration of Kv4.2•1. Purple bar indicates illumination. 
Gray circles, 0 nM control; rate = 0.00015 ± 0.00004 s1 and f = 
1; black circles: 0.5 nM, rate = 0.019 ± 0.003 s1 and f = 0.30 ± 
0.02; 2.5 nM, rate = 0.021 ± 0.002 s1 and f = 0.86 ± 0.02; 10 nM, 
rate = 0.052 ± 0.001 s1 and f = 0.953 ± 0.004. (B) Summary data 
of Kv4.2•1 concentration versus photoinhibitory rates derived 
from exponential fitting. Circles, individual cells. 0 nM, n = 10; 
2.5 nM, n = 5; 10 nM, n = 6.
Figure 6. Block of photoablation by antigenic peptide. (A) Anti-
Kv4.2 mAb binding to antigen is blocked by preincubation with 
soluble Kv4.2e peptide. ELISA binding assays. Abscissa is normal-
ized to absorbance of 80 nM Kv4.2 mAb. Black circles, readings 
from individual wells; n = 16–21; gray circles, preincubation with 
1 µM Kv4.2e blocking peptide; n = 5–15. Lines are fits of Langmuir 
binding isotherm: Kd Kv4.2 mAb = 23 ± 1 nM and +Kv4.2e pep-
tide = 4,200 ± 2,600 nM. Bars, mean ± SEM. (B) Dose–response 
of antigenic peptide block. Gray circles, ELISA assays of 5 nM 
Kv4.2 mAb with increasing concentration of Kv4.2e peptide; 
n = 16–24. Fit of Langmuir isotherm has IC50 of 6.5 ± 1.1 nM. 
Bars, mean ± SEM. (C) Partial block of Kv4.2 photoablation by 
Kv4.2e peptide. Data points are relative peak currents from Kv4.2 
CHO cells during 0-mV pulses. Purple bar indicates illumination. 
Circles, photoablation of Kv4.2 with 2.5 nM Kv4.2•1; rate = 0.039 ± 
0.001 s1 and f = 0.82 ± 0.01; triangles, same as circles except 
Kv4.2•1 was preincubated with 10 µM Kv4.2 peptide; rate = 0.041 ± 
0.002 s1 and f = 0.261 ± 0.003; triangles, 100 µM Kv4.2 peptide; 
rate = 0.050 ± 0.003 s1 and f = 0.273 ± 0.004.
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In attempts to prevent background photoablation, a panel 
of reducing agents was added to the patch pipette, includ-
ing 10 mM of reduced glutathione, 25 mM potassium 
ascorbate, 500 U/ml superoxide dismutase, 50 mM dithio-
threitol, and 40 µM trolox C. These reducing agents 
were not effective at preventing background photoabla-
tion (unpublished data).
Another complicating facet of applying antibody–
porphyrin-guided photoablation to patch-clamp studies 
was a variable level of photostimulated leak current that 
sometimes occurred. Leak currents occurred frequently, 
but inconsistently, after photostimulation of cells exposed 
to antibody–porphyrin conjugates. An example of the 
membrane leak sometimes accompanying photoabla-
tion is shown in Fig. 8 (D and E). Photostimulation in-
consistently triggered an increased leakiness of the 
membrane that could further develop after cessation of 
illumination. A previous study using reactive oxygen–
mediated photoablation of membrane proteins reported 
collateral damage to other cellular proteins (Guo et al., 
2006), and the leak currents appearing in our experi-
ments appear to be a manifestation of some form of col-
lateral oxidative damage.
D I S C U S S I ON
We have found that antibody-guided, porphyrin-mediated 
photoablation can select among Kv4 subtypes. This 
method of targeting channels yielded better specificity 
for Kv4.2 over Kv4.3 and Kv2.1 than any inhibitor we are 
aware of. Ablation of currents with conjugates of benign 
antibodies offers a new route toward pinpointing the 
molecular identity of endogenous channels underlying 
ionic current.
Porphyrin-conjugated derivatives of an anti-Kv mAb 
imbued photoablation specificity against a targeted Kv 
channel. This method also inflicted collateral damage 
against other channels and likely the cell membrane 
itself. The mechanism of collateral damage is unclear. 
We speculate that it is caused by an innate affinity of 
porphyrins for cell membranes, resulting in nonspecific 
adsorption of porphyrin–mAb conjugates to cell surfaces. 
Upon photostimulation, singlet oxygen from the adsorbed 
conjugates could harm other channels, damage the mem-
brane to increase electrical leak, and inflict additional 
undetected forms of oxidative damage to the cell. This 
collateral damage is consistent with side effects noted 
by Guo et al. (2006) when photostimulating fluorescein 
conjugates on cell surfaces. Nonetheless, porphyrin con-
jugates have been useful in demonstrating the concept 
of antibody-guided Kv inhibition. This strategy could be 
improved upon by conjugating less technically problem-
atic inhibitors.
We are currently working to conjugate promiscuous 
inhibitors of Kv channels to anti-Kv mAbs while retain-
ing the function of both components. The ability of 
Figure 8. Properties of photoablation. Recordings from HEK 
cells expressing Kv4.2 with inactivation reduced. P/n subtrac-
tion was used to isolate K currents. (A) Detail of Kv4.2 current 
activation and deactivation. Black line, 10 nM Kv4.2•1 before 
illumination; purple line, after 10-s illumination. (B) The level 
of photoablation does not change after cessation of illumina-
tion. Circles, peak Kv4.2 currents during 0-mV pulses with 10 nM 
Kv4.2•1. Purple bar indicates illumination; rate = 0.083 ± 0.006 s1 
and f = 0.87 ± 0.03. (C) Example of endogenous photosensitivity. 
Circles, peak Kv4.2 currents during 0-mV pulses without any por-
phyrin–mAb conjugate. Purple bar indicates illumination; rate = 
0.00221 ± 0.00002 s1 and f = 1. (D) Sequential illumination pulses 
reveal that photoablation can be achieved through repetitive puls-
ing. Circles, peak Kv4.2 currents during 0-mV pulses with 10 nM 
Kv4.2•1. Purple bar indicates illumination. (E) Example of vari-
able leak triggered by photoablation. Same cell as D. Input resistance 
measured by inward current at a holding potential of 100 mV.
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